ATAGI update following weekly COVID-19 meeting (14 July 2021)

15 July 2021 - An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 14 ...

Read more →

COVID-19 vaccine weekly safety report (15 July 2021)

15 July 2021 - Seven additional cases of blood clots with low blood platelets have been assessed as thrombosis with thrombocytopenia ...

Read more →

Prescription medicines: applications under evaluation (July 2021 update)

14 July 2021 - The TGA has updated its list of applications for new medicines/vaccines or new uses for existing medicines/vaccines ...

Read more →

ATAGI statement on use of COVID-19 vaccines in an outbreak setting

13 July 2021 - A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of COVID-19 vaccines ...

Read more →

ATAGI update following weekly COVID-19 meeting – 7 July 2021

8 July 2021 - An update from the Australian Technical Advisory Group on Immunisation following their weekly meeting on 7 July ...

Read more →

COVID-19 vaccine weekly safety report (8 July 2021)

8 July 2021 - Seven additional cases of blood clots with low blood platelets have been assessed as thrombosis with thrombocytopenia ...

Read more →

Statement for health care professionals: how COVID-19 vaccines are regulated for safety and effectiveness

5 July 2021 - Joint Statement from the International Coalition of Medicines Regulatory Authorities and World Health Organization. ...

Read more →

Medical devices reforms: enhancements to post-market monitoring

5 July 2021 - This project has been established to enhance the adverse event reporting processes. ...

Read more →

COVID-19 vaccine weekly safety report (1 July 2021)

1 July 2021 - Five additional cases of blood clots with low blood platelets have been assessed as thrombosis with thrombocytopenia ...

Read more →

COVID-19 vaccine weekly safety report (24 June 2021)

24 June 2021 - Five additional cases of blood clots with low blood platelets have been assessed as thrombosis with thrombocytopenia ...

Read more →

TGA grants third provisional approval to COVID-19 vaccine: Janssen

25 June 2021 - On 25 June 2021, the TGA granted provisional approval to Janssen-Cilag for its COVID-19 vaccine Janssen, ...

Read more →

TGA grants provisional determination for the Moderna COVID-19 vaccine, Elasomeran

24 June 2021 - Today, the Therapeutic Goods Administration granted provisional determination to Moderna Australia in relation to the COVID-19 ...

Read more →

Fees and charges: summary from 1 July 2021

23 June 2021 - The TGA is required to recover its costs for all activities that fall within the scope of ...

Read more →

TGA approves first generic pomalidomide

23 June 2021 - The TGA has approved first generic version of Celgene's Pomalyst. ...

Read more →

Australia-Canada-Singapore-Switzerland-United Kingdom (Access) Consortium

22 June 2021 - The TGA is a member of the Access consortium along with Health Canada, Health Sciences Authority of ...

Read more →